Skip to main content
OpenTrials
Completed

NCT Number: NCT06931587

Methanol Poisoning

This study addresses methyl alcohol intoxications with profound acidosis requiring intensive care treatment. The goal is to contribute both to the improvement of diagnosis and follow-up processes and to the development of management strategies under the highlight of existing literature.

This study is a single-center, retrospective, observational cohort study conducted on patients admitted to the ICU between January 2022 and March 2025 with suspected or laboratory-confirmed methyl alcohol intoxication. The investigators analyzed patients' demographic characteristics, prognostic clinical and laboratory parameters, treatment approaches and outcomes

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Kartal Dr. Lütfi Kırdar City Hospital

Kartal, Istanbul, 34870, Turkey (Türkiye)

About this study

This study addresses methyl alcohol intoxications with profound acidosis requiring intensive care treatment. The objective is to contribute to the improvement of diagnostic and follow-up processes, as well as to the development of management strategies, in light of the existing literature.

The study is a single-center, retrospective, observational cohort analysis conducted on patients admitted to the intensive care unit (ICU) between January 2022 and March 2025 with suspected or laboratory-confirmed methyl alcohol intoxication.

Data collection was performed in three steps. Initially, the hospital's electronic medical database was searched using the ICD code T51.1 to identify relevant cases. Subsequently, detailed medical records were reviewed to assess clinical progress and treatment interventions. Finally, laboratory findings were obtained through the hospital's patient record system.

Demographic characteristics-including age and gender-reasons for ICU admission, pre-existing conditions, presenting symptoms, and disease severity based on Acute Physiology and Chronic Health Evaluation II (APACHE II), Glasgow Coma Scale (GCS), Sequential Organ Failure Assessment (SOFA), and Simplified Acute Physiology Score (SAPS) evaluated during the first 24 hours of ICU stay were retrospectively analyzed. Treatment interventions, including ethanol or fomepizole administration, the need for hemodialysis (intermittent hemodialysis [IHD] or continuous venovenous hemodialysis [CVVHD]), supportive therapies, ICU length of stay, and clinical outcomes were also documented.

Laboratory evaluations included arterial blood gas analysis, anion gap, osmolality, complete blood count, glucose, urea, creatinine, electrolytes (sodium, potassium, chloride), C-reactive protein (CRP), and organ function tests such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT).

Demographic data, prognostic clinical and laboratory parameters, treatment modalities, and clinical outcomes were analyzed by the investigators.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of methyl alcohol intoxication.

Exclusion criteria

  • Other toxic alcohol intoxications
  • Pregnant women

Treatment and study plan

Primary outcomes

  1. ICU Mortality Among Patients With Methyl Alcohol Intoxication

    Time frame: Up to 30 days (during ICU follow-up)

    Mortality was defined as death occurring during ICU stay among patients admitted with laboratory-confirmed or suspected methyl alcohol intoxication.

Sponsors and collaborators

Lead sponsor

Kartal City Hospital

Other

Registry information

Official study title

Methyl Alcohol Intoxication as a Public Health Issue: A 3-Year Retrospective Analysis

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 17, 2025
Registry last updated
Apr 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.